SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 32.00 |
| Enterprise Value ($M) | 4.09 |
| Book Value ($M) | 103.07 |
| Book Value / Share | 14.11 |
| Price / Book | 0.31 |
| NCAV ($M) | 98.13 |
| NCAV / Share | 13.43 |
| Price / NCAV | 0.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.09 |
| Current Ratio | 7.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 120.32 |
| Assets | 125.26 |
| Liabilities | 22.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -89.14 |
| Net Income | -83.74 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -74.21 |
| Cash from Investing | 80.43 |
| Cash from Financing | 0.10 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | |||
| 13D | Tang Capital Management Llc | 9.90 | ||
| 13G/A | BlackRock, Inc. | 1.10 | -82.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,241 | 31,197 | 10.39 | |
| 11,574 | 23,460 | 49.34 | |
| 532 | 4,913 | 10.83 | |
| 1,315 | 9,591 | 13.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KRON – Kronos Bio, Inc. | KRRO – Korro Bio, Inc. |
| KTTA – Pasithea Therapeutics Corp. | LEXX – Lexaria Bioscience Corp. |
| LFVN – LifeVantage Corporation |
Financial data and stock pages provided by
Fintel.io